F87-30311-35501
2 vaccinations
1 coded response
10 check-ins
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 12-15
- ZIP prefix
- 481 / MI
- Registered
- 2021-08-23
- Relationship
- Child or adolescent in my care
- Guardian
- 3X7-11093-34031
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-07-31
Dose 1 — Pfizer-BioNTech
-
2021-08-21
Dose 2 — Pfizer-BioNTech
-
2021-08-23
Registered in v-safe
-
2021-08-23
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-08-25
- 2021-08-26
- 2021-08-28
- 2021-09-07
- 2021-09-19
- 2021-09-30
-
2021-10-06
Survey response — day 42, dose 2, dependentMedDRA: Fatigue, Nasal disorder, Nasopharyngitis, Sinus disorder — Feeling: Fair · Be unable to work or attend schoolFree text: has cold nose/sinus symptoms and fatigue but not covidMedDRA releases: 2024-11 · check-in free text available
- 2021-11-23
- 2022-02-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-31 | Pfizer-BioNTech | No |
| 2 | 2021-08-21 | Pfizer-BioNTech | No |
Free text
Release 10 — day 42, dose 2, dependent
Symptoms: has cold nose/sinus symptoms and fatigue but not covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | · | · | ✓ |
| SD | Nasal disorder | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Sinus disorder | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release